Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim

Abstract Congenital amegakaryocytic thrombocytopenia (CAMT) is an inherited disorder characterized at birth by thrombocytopenia with reduced megakaryocytes, which evolves into generalized bone marrow aplasia during childhood. Although CAMT is genetically heterogeneous, mutations of MPL, the gene enc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Alessandro Pecci, Iman Ragab, Valeria Bozzi, Daniela De Rocco, Serena Barozzi, Tania Giangregorio, Heba Ali, Federica Melazzini, Mohamed Sallam, Caterina Alfano, Annalisa Pastore, Carlo L Balduini, Anna Savoia
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer Nature 2017-11-01
Edice:	EMBO Molecular Medicine
Témata:	congenital amegakaryocytic thrombocytopenia MPL mutation romiplostim thrombopoietin
On-line přístup:	https://doi.org/10.15252/emmm.201708168
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!